Status:

UNKNOWN

Chromogranin-A-Derived Peptides and Periodontitis in Diabetic Patients

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Periodontitis and Diabetitis

Eligibility:

All Genders

20-80 years

Phase:

NA

Brief Summary

Periodontitis is a chronic disease of the supporting tissue of the teeth, characterized by bleeding and inflamed gingival, resorption of alveolar bone. This disease has a significant impact of the qua...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Patients from 20 to 80 years old
  • A minimum of 10 teeth
  • Healthy volunteers or diabetic patients with or without periodontitis
  • Exclusion criteria:
  • a course of antibiotics
  • a fungicidal therapy
  • a corticotherapy
  • a hormone therapy
  • a pregnancy
  • persons under guardianship

Exclusion

    Key Trial Info

    Start Date :

    March 1 2008

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    90 Patients enrolled

    Trial Details

    Trial ID

    NCT00399620

    Start Date

    March 1 2008

    Last Update

    January 12 2009

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Département de Parodontologie - Hôpital Civil

    Strasbourg, France, 67091

    Chromogranin-A-Derived Peptides and Periodontitis in Diabetic Patients | DecenTrialz